2m 2m 2m 2m 2m 2m 2m
LIMINATUS (LIMN)
NASDAQ
$0.15-$0.05 (-23.08%)
Price as of Jun 03, 2026 7:50 PM EDT- $7.4MMarket Cap
- -96.32%1-Year Change
- BiotechnologyIndustry
LIMINATUS (LIMN)
$0.15-$0.05 (-23.08%)
LIMN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.20 | ||
Change | +$0.01 (+8.27%) | ||
Open | $0.19 | ||
High | $0.21 | ||
Low | $0.18 | ||
Previous Close | $0.18 | ||
Volume | 10,233,660 | ||
30-Day Average Volume | 19,638,071 | ||
1-Week Change | 18.97% | ||
1-Month Change | -4.97% | ||
1-Year Change | -96.32% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.9M | ||
Total Assets | $2.8M | ||
Market Cap | $7.4M | ||
Enterprise Value | $6.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.1M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$1.1M | ||
EBITDA | -$1.1M | ||
Net Working Capital | -$110,877.00 | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -56 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue